Martin Bradstreet@ALEXEIMARTOV

I wrote up $BDSX / Biodesix, a small cap diagnostics company with a best in class lung cancer test (Link in bio). Last quarter BDSX grew revenues 35%, with 82% gross margins and ASPs over $1200 (strong for diagnostics). Yet it trades at under 3x revenue. There is also a

tweeted Mon, Aug 24 · counted from Tue, Aug 25 close